Elon Musk's Neuralink Receives FDA Approval for Human Trials
Written on
Chapter 1: Neuralink's Historic Announcement
Neuralink, the brainchild of Elon Musk, has recently revealed that it has secured authorization to initiate human trials for its brain chip implants. This pivotal announcement was made via a tweet, signaling a noteworthy shift from previous rejections by the Food and Drug Administration (FDA). Just months prior, in March 2023, the FDA had denied approval for the third time, raising numerous concerns about the safety of the technology.
“We are thrilled to share that we’ve received FDA clearance to start our inaugural clinical trial involving human participants,” Neuralink stated on its Twitter. The company has yet to open applications for volunteers, but it promises to provide updates shortly.
The unexpected nature of this announcement has caught many off guard, particularly given the FDA's earlier hesitations. The agency had expressed serious concerns regarding the potential health risks associated with these brain implants.
Section 1.1: Safety Concerns Surrounding Brain Implants
Some of the FDA's worries include the risk of toxicity related to lithium batteries used in the implanted devices. There are also fears that the wires from the implants could shift and interfere with brain function, alongside complications that might arise during the removal process, potentially harming brain tissue.
Photo by David Matos on Unsplash
Section 1.2: Previous Investigations into Neuralink
In addition to these health concerns, Neuralink faced scrutiny in 2022 when it was investigated for alleged breaches of the Animal Welfare Act. Reports indicated that the company was responsible for the deaths of around 1,500 animals—including sheep, pigs, and monkeys—during its experiments since 2018.
Moreover, in February 2023, the U.S. Department of Transportation launched another investigation into the company due to mishandling of pathogens during a research collaboration with the University of California. These incidents raise valid questions about the ethics and safety of participating in Neuralink's human trials.
Chapter 2: Potential Collaboration with Barrow Neurological Institute
Despite the lack of official announcements on the FDA's website, the recent approval may be linked to Neuralink's partnership with the Barrow Neurological Institute in Phoenix, Arizona. This institute is known for its innovative work in human brain implant experimentation.
The first video title is "Elon Musk's Neuralink Can Now Experiment on Humans" - YouTube. This video discusses Neuralink’s recent FDA approval and the implications for brain implant technology.
The second video title is "Neuralink Begins First Human Experiments!" - YouTube. This video explores Neuralink's transition into human trials, highlighting the potential risks and benefits involved.